본문 바로가기

카테고리 없음

Dravet Syndrome Market Size and Share

According to the Dravet Syndrome Foundation, Dravet syndrome (DS) is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures.

 

As per NORD (National Organization for Rare Disorders), it has been defined as a severe form of epilepsy characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, speech impairment, ataxia, hypotonia, sleep disturbances, and other health problems.

Dravet Syndrome Market Size and Share

Dravet Syndrome Market Size and Share

Market Size of Dravet Syndrome (DS) in the 7MM was found to be $5,635 million in 2017.

As per DelveInsight’s estimates, the total incident population of Dravet Syndrome in the 7 major markets was 36,301 in 2017.

As per DelveInsight’s estimates, the United States accounted for the maximum number of DS patients with 20,731 cases in 2017 followed by Germany with 2,896 cases.

 

Dravet Syndrome Market

DelveInsight’s “Dravet Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Dravet Syndrome, historical and forecasted epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Key Benefits of Dravet Syndrome Market Report

  • Dravet Syndrome market report provides an in-depth analysis of Dravet Syndrome Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

  • The Dravet Syndrome market report will help in developing business strategies by understanding the Dravet Syndrome Market trends & developments, key players and future market competition that will shape and drive the Dravet Syndrome market in the upcoming years.

  • The Dravet Syndrome market report covers Dravet Syndrome current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Dravet Syndrome market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors.

 

For more information visit: 

https://www.delveinsight.com/report-store/dravet-syndrome-market